Immune globulin subcutaneous (Human)

BIOLOGICAL3 trials

Sponsors

CSL Behring, University of South Florida

Conditions

Chronic Inflammatory Demyelinating PolyneuropathyPrimary Immune DeficiencyPrimary Immune Deficiency Disorder

Phase 3

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

CompletedNCT01458171

CSL BehringPrimary Immune Deficiency Disorder

Start: 2011-04-30End: 2012-04-30Updated: 2013-04-09

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

CompletedNCT01461018

CSL BehringPrimary Immune Deficiency

Start: 2011-10-31End: 2014-07-31Updated: 2014-12-02

Unknown Phase

Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

CompletedNCT02465359

University of South FloridaChronic Inflammatory Demyelinating Polyneuropathy

Start: 2014-09-30End: 2021-05-31Updated: 2024-10-08